Fibrin, formation

Albumin and amino acid loss Muscle wasting Increased adipose tissue Fibrin formation in dialysate... 

Activated factor XII leads to the activation of factor XI in turn, activated factor XI, along with Ca++ ions and factor IV, leads to activation of factor IX. Activated factor IX, along with Ca++ ions, factor VIII, and PF3, leads to the activation of factor X. From the point of factor X activation, the extrinsic and intrinsic mechanisms follow the same pathway to fibrin formation. 

Mechanism of action - Argatroban is a synthetic, direct thrombin inhibitor that reversibly binds to the thrombin active site. It inhibits thrombin-catalyzed or induced reactions, including fibrin formation activation of coagulation factors V, VIII, and XIII protein C and platelet aggregation. 

H.J. Weiss, V.T. Turitto, H.R. Baumgartner, Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects, J. Clin. Invest. 78 (1986) 1072-1082. 

Bemocco, S., Ferri, F., Profumo, A., Cuniberti, C., and Rocco, M. (2000). Polymerization of rod-like macromolecular monomers studied by stopped-flow, multiangle light scattering Set-up, data processing, and application to fibrin formation. Biophys.J. 79, 561—583. 

Blomback, B. (1991). Fibrinogen and Fibrin Formation and Its Role in Fibrinolysis. In Biotechnology of Blood (J. Goldstein, Ed.), pp. 225-279. Butterworth-Heinemann, Boston. 

Freyssinet, J. M., Torbet.J., Hudry-Clergeon, G., and Maret, G. (1983). Fibrinogen and fibrin structure and fibrin formation measured by using magnetic orientation. Proc. Natl. Acad. Sci. USA 80, 1616-1620. 

Mosesson, M. W. (2003). Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb. Haemost. 89, 9-12. 

The platelet is central to normal hemostasis and to all thromboembolic disease. A white thrombus forms initially in high-pressure arteries by adherence of circulating platelets to areas of abnormal endothelium as described above. The growing thrombus of aggregated platelets reduces arterial flow. This localized stasis triggers fibrin formation, and a red thrombus forms around the nidal white thrombus. 

Hettasch JM, Greenberg CS. Fibrin formation and stabilization. In LoscalzoJ, Schafer Al, eds. Thrombosis and Hemorrhage, 2nd ed. Baltimore, MD Williams Wilkins, 1998 129-154. 

Fig.7 Blood compatibility of PEU surfaces modified by MPEO-derived SMAs. A Simplified cascade model for material-induced blood coagulation highlighting three clotting pathways plasma fibrin formation, platelet aggregation, and hemolysis-inflammation, respectively characterized by B-C...

Thrombin Time (TT). To 0.1 ml of citrated plasma 0.1 ml of diethylbarbiturate-citrate buffer, pH 7.6 (Behring Werke, Marburg) is added and the mixture is incubated for 1 min at 37 °C. Then 0.1 ml of bovine test-thrombin (30 IU/ml, Behring Werke, Marburg) is added and the coagulometer is started. The time to clot formation is determined. The TT measures effects on fibrin formation. 

Reaction time (r) the time from sample placement in the cup until onset of clotting (defined as amplitude of 1 mm). This represents the rate of initial fibrin formation. 

Plasmin. Generated by proteolytic cleavage of plasminogen, a plasma protein synthesised in the liver. Cleavage is catalysed by tissue plasmiuogeu activator (t-PA), which is synthesised and secreted by endothefium. Plasmin proteolytically cleaves fibrin into fibrin degradation products, which inhibits excessive fibrin formation. 

---